1. Drug spending rose 84 percent from 1993 to 1998. BNA’s Health Care Policy Report. 1999, 7: 1185-
2. McDonagh M, Carson S: Drug class review: Proton Pump Inhibitors. Drug Effectiveness Review Project. 2002, Oregon Health & Science University, Portland, vol.
http://derp.ohsu.edu/about/final-document-display.cfm#tab-2
,
3. The Agency for Healthcare Research and Quality is listed as the author of this compilation of chapters on methods: The suggested citations: Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 10(11)-EHC063-EF. Agency for Healthcare Research and Quality, Rockville, MD, Accessed at:
http://www.effectivehealthcare.ahrq.gov/ehc/products/60/318/MethodsGuide_Prepublication_Draft_20110824.pdf
2011,
4. Norris SL, Atkins D, Bruening W, Fox S, Johnson E, Kane R, Morton SC, Oremus M, Ospina M, Randhawa G, Schoelles K, Shekelle P, Viswanathan M: Observational studies in systemic reviews of comparative effectiveness: AHRQ and the Effective Health Care Program. J Clin Epidemiol. 2011, 64: 1178-1186. 10.1016/j.jclinepi.2010.04.027.
5. Chou R, Aronson N, Atkins D, Ismaila AS, Santaguida P, Smith DH, Whitlock E, Wilt TJ, Moher D: AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol. 2010, 63: 502-512. 10.1016/j.jclinepi.2008.06.007.